EMA publishes noncompliance letters

Share this article:

EMA warning letters now have a publisher. Pharmafile reports that the European Medicines Agency (EMA) is now publishing the names of companies which fail to meet Good Manufacturing Practice Standards. Pharmafile says the EudraGMDP database, which includes all non-compliance report entries going back to 2007, lists 83 non-compliance reports.

Four US manufacturing sites are among the violators, preceded by China, which has 22 non-compliance notices, and India, which has 35.

The database was initially set up to make manufacturing and import approvals public and was first known as the EudraGMP.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.